Cusi, K. et al. Non-alcoholic fatty liver disease (NAFLD) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes. Diabetes Obes. Metab. 19 (11), 1630–1634 (2017).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Pimpin, L. et al. Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies. J. Hepatol. 69 (3), 718–735 (2018).ArticleÂ
PubMedÂ
Google ScholarÂ
Cusi, K. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. Gastroenterology. 142 (4), 711–725e716 (2012).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Masoodi, M. et al. Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests. Nat. Rev. Gastroenterol. Hepatol. 18 (12), 835–856 (2021).ArticleÂ
PubMedÂ
Google ScholarÂ
Choi, H. J. et al. The inhibitory effects of Geranium thunbergii on interferon-gamma- and LPS-induced inflammatory responses are mediated by Nrf2 activation. Int. J. Mol. Med. 35 (5), 1237–1245 (2015).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Nathan, C. Nonresolving inflammation redux. Immunity. 55 (4), 592–605 (2022).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Fang, Y. et al. Pyroptosis: A new frontier in cancer. Biomed. Pharmacother 121, 109595 (2020).Wei, X. et al. Role of pyroptosis in inflammation and cancer. Cell. Mol. Immunol. 19 (9), 971–992 (2022).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Man, S. M., Karki, R. & Kanneganti, T. D. Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases. Immunol. Rev. 277 (1), 61–75 (2017).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Man, S. M. & Kanneganti, T. D. Converging roles of caspases in inflammasome activation, cell death and innate immunity. Nat. Rev. Immunol. 16 (1), 7–21 (2016).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
de Carvalho Ribeiro, M. & Szabo, G. Role of the inflammasome in liver disease. Annu. Rev. Pathol. 17, 345–365 (2022).ArticleÂ
PubMedÂ
Google ScholarÂ
Xia, X. et al. The role of pyroptosis in cancer: pro-cancer or pro-host? Cell Death Dis. 10 (9), 650 (2019).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Elias, E. E., Lyons, B. & Muruve, D. A. Gasdermins and pyroptosis in the kidney. Nat. Rev. Nephrol. 19 (5), 337–350 (2023).ArticleÂ
PubMedÂ
Google ScholarÂ
Tsuchida, T. & Friedman, S. L. Mechanisms of hepatic stellate cell activation. Nat. Rev. Gastroenterol. Hepatol. 14 (7), 397–411 (2017).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Xiao, Y. et al. STING mediates hepatocyte pyroptosis in liver fibrosis by epigenetically activating the NLRP3 inflammasome. Redox Biol. 62, 102691 (2023).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Kanehisa, M. et al. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51 (D1), D587–D592 (2023).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28 (1), 27-30 (2000). Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28 (11), 1947-1951 (2019). van Egmond, M. B. et al. Privacy-preserving dataset combination and Lasso regression for healthcare predictions. BMC Med. Inf. Decis. Mak. 21 (1), 266 (2021).ArticleÂ
Google ScholarÂ
Friedman, J., Hastie, T. & Tibshirani, R. Regularization paths for generalized linear models via coordinate descent. J. Stat. Softw. 33 (1), 1–22 (2010).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Ding, L. et al. Identification of cuproptosis-related subtypes, cuproptosis-related gene prognostic index in hepatocellular carcinoma. Front. Immunol. 13, 989156 (2022).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Joshi, P., Vedhanayagam, M. & Ramesh, R. An ensembled SVM based approach for predicting adverse drug reactions. Curr. Bioinform. 16 (3), 422–432 (2021).ArticleÂ
CASÂ
Google ScholarÂ
Xu, H. et al. Identification of miRNA signature associated with erectile dysfunction in type 2 diabetes mellitus by support vector machine-recursive feature elimination. Front. Genet. 12, 762136 (2021).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Yang, X-F. et al. Predicting LncRNA subcellular localization using unbalanced pseudo-k nucleotide compositions. Curr. Bioinform. 15 (6), 554–562 (2020).ArticleÂ
CASÂ
Google ScholarÂ
Abinash, M. J. & Vasudevan, V. Boundaries tuned support vector machine (BT-SVM) classifier for cancer prediction from gene selection. Comput. Methods Biomech. Biomed. Eng. 25 (7), 794–807 (2022).ArticleÂ
CASÂ
Google ScholarÂ
Sanz, H. et al. SVM-RFE: selection and visualization of the most relevant features through non-linear kernels. BMC Bioinform. 19 (1), 432 (2018).ArticleÂ
Google ScholarÂ
Rigatti, S. J. Random Forest. J. Insur Med. 47 (1), 31–39 (2017).ArticleÂ
PubMedÂ
Google ScholarÂ
Robin, X. et al. pROC: an open-source package for R and S + to analyze and compare ROC curves. BMC Bioinform. 12, 77 (2011).ArticleÂ
Google ScholarÂ
Yu, G. et al. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 16 (5), 284–287 (2012).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Cotto, K. C. et al. DGIdb 3.0: a redesign and expansion of the drug-gene interaction database. Nucleic Acids Res. 46 (D1), D1068–D1073 (2018).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Wu, J. et al. Comprehensive analysis of pyroptosis-related genes and Tumor Microenvironment Infiltration characterization in breast Cancer. Front. Immunol. 12, 748221 (2021).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Xiao, J. et al. Global liver disease burdens and research trends: analysis from a Chinese perspective. J. Hepatol. 71 (1), 212–221 (2019).ArticleÂ
PubMedÂ
Google ScholarÂ
Eng, J. M. & Estall, J. L. Diet-Induced models of non-alcoholic fatty liver disease: food for thought on sugar, fat, and cholesterol. Cells, 10(7), 1805 (2021).Rao, Z. et al. Pyroptosis in inflammatory diseases and cancer. Theranostics. 12 (9), 4310–4329 (2022).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Zhaolin, Z. et al. Role of pyroptosis in cardiovascular disease. Cell Prolif. 52 (2), e12563 (2019).ArticleÂ
PubMedÂ
Google ScholarÂ
Li, S. et al. NLRP3/caspase-1/GSDMD-mediated pyroptosis exerts a crucial role in astrocyte pathological injury in mouse model of depression. JCI Insight. 6(23), e146852(2021).Jin, C. J. et al. Loss of lipopolysaccharide-binding protein attenuates the development of diet-induced non-alcoholic fatty liver disease in mice. J. Gastroenterol. Hepatol. 32 (3), 708–715 (2017).ArticleÂ
MathSciNetÂ
CASÂ
PubMedÂ
Google ScholarÂ
Matsushita, N. et al. Effect of Lipopolysaccharide on the progression of non-alcoholic fatty liver Disease in High Caloric Diet-Fed Mice. Scand. J. Immunol. 83 (2), 109–118 (2016).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Li, Z. et al. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology. 37 (2), 343–350 (2003).ArticleÂ
ADSÂ
MathSciNetÂ
CASÂ
PubMedÂ
Google ScholarÂ
Softic, S., Cohen, D. E. & Kahn, C. R. Role of dietary fructose and hepatic de novo lipogenesis in fatty liver disease. Dig. Dis. Sci. 61 (5), 1282–1293 (2016).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Ioannou, G. N. The role of cholesterol in the pathogenesis of NASH. Trends Endocrinol. Metab. 27 (2), 84–95 (2016).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Minami, Y. et al. Liver lipophagy ameliorates nonalcoholic steatohepatitis through extracellular lipid secretion. Nat. Commun. 14 (1), 4084 (2023).ArticleÂ
ADSÂ
MathSciNetÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Priyanka, M. et al. Late stage specific Rv0109 (PE_PGRS1) protein of Mycobacterium tuberculosis induces mitochondria mediated macrophage apoptosis. Microb. Pathog. 176, 106021 (2023).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Wilson, C. H. & Kumar, S. Caspases in metabolic disease and their therapeutic potential. Cell Death Differ. 25 (6), 1010–1024 (2018).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Kawai, T. & Akira, S. TLR signaling. Cell Death Differ. 13 (5), 816–825 (2006).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Seki, E. & Brenner, D. A. Toll-like receptors and adaptor molecules in liver disease: update. Hepatology. 48 (1), 322–335 (2008).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Suganami, T. et al. Role of the toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler. Thromb. Vasc Biol. 27 (1), 84–91 (2007).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Liu, Z. et al. Caspase-1 engages full-length gasdermin D through two distinct interfaces that mediate caspase recruitment and substrate Cleavage. Immunity. 53 (1), 106–114e105 (2020).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Katoh, M. & Katoh, M. Identification and characterization of human DFNA5L, mouse Dfna5l, and rat Dfna5l genes in silico. Int. J. Oncol. 25 (3), 765–770 (2004).CASÂ
PubMedÂ
Google ScholarÂ
Saeki, N. et al. Distinctive expression and function of four GSDM family genes (GSDMA-D) in normal and malignant upper gastrointestinal epithelium. Genes Chromosomes Cancer. 48 (3), 261–271 (2009).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Rieckmann, J. C. et al. Social network architecture of human immune cells unveiled by quantitative proteomics. Nat. Immunol. 18 (5), 583–593 (2017).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Shi, J. et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 526 (7575), 660–665 (2015).ArticleÂ
ADSÂ
CASÂ
PubMedÂ
Google ScholarÂ
Kayagaki, N. et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature. 526 (7575), 666–671 (2015).ArticleÂ
ADSÂ
CASÂ
PubMedÂ
Google ScholarÂ
Mridha, A. R. et al. NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice. J. Hepatol. 66 (5), 1037–1046 (2017).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Gaul, S. et al. Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis. J. Hepatol. 74 (1), 156–167 (2021).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Wang, J. Y. et al. Potential regulatory role of lncRNA-miRNA-mRNA axis in osteosarcoma. Biomed. Pharmacother. 121, 109627 (2020).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Wang, L. et al. Long noncoding RNA (lncRNA)-Mediated competing endogenous RNA networks provide Novel potential biomarkers and therapeutic targets for colorectal cancer. Int. J. Mol. Sci. 20(22), 5758 (2019).Hu, B. et al. The mRNA-miRNA-lncRNA regulatory network and factors associated with prognosis prediction of hepatocellular carcinoma. Genom. Proteom. Bioinform. 19 (6), 913–925 (2021).ArticleÂ
CASÂ
Google ScholarÂ